Lizhi Inc. LIZI

Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi

-- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.

Lets go Lizi to the moon ?

Lets go Lizi! To the moon ? ?

Come on Lizi girl get your sea legs under you and climb this mountain ⛰️ ? ?

Need more action, get in while your can before the rocket ship ? ?. Lizi to the ?

Lets go! Nice bounce back from yesterday wow ? ?

Lets go Lizi! To the ? ?

Lizi on ? ?

Rocket launching in T minus 5 days and counting ? ?

Lets go Lizi to the ? ?